Joanne Verheij

19.4k total citations · 1 hit paper
308 papers, 9.3k citations indexed

About

Joanne Verheij is a scholar working on Surgery, Epidemiology and Oncology. According to data from OpenAlex, Joanne Verheij has authored 308 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Surgery, 96 papers in Epidemiology and 90 papers in Oncology. Recurrent topics in Joanne Verheij's work include Cholangiocarcinoma and Gallbladder Cancer Studies (62 papers), Liver Disease Diagnosis and Treatment (62 papers) and Pancreatic and Hepatic Oncology Research (55 papers). Joanne Verheij is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (62 papers), Liver Disease Diagnosis and Treatment (62 papers) and Pancreatic and Hepatic Oncology Research (55 papers). Joanne Verheij collaborates with scholars based in Netherlands, United States and United Kingdom. Joanne Verheij's co-authors include Thomas M. van Gulik, Albert J. Bredenoord, Ulrich Beuers, Max Nieuwdorp, Jan N.M. IJzermans, Adriaan G. Holleboom, Bram D. van Rhijn, Julia J. Witjes, Andreas J. Smout and Judith Aron‐Wisnewsky and has published in prestigious journals such as Nature Communications, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Joanne Verheij

296 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

2020 768 citations Adriaan G. Holleboom, Joanne Verheij et al. profile →

Peers

Countries citing papers authored by Joanne Verheij

Since Specialization

Citations

This map shows the geographic impact of Joanne Verheij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Verheij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Verheij more than expected).

Fields of papers citing papers by Joanne Verheij

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Verheij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Verheij. The network helps show where Joanne Verheij may publish in the future.

Co-authorship network of co-authors of Joanne Verheij

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Verheij. A scholar is included among the top collaborators of Joanne Verheij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Verheij. Joanne Verheij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry 2025 ·International Journal of Cancer ·Lydia G. van der Geest, Marianne van der Mark, Joanne Verheij, Arantza Fariña Sarasqueta, Judith de Vos‐Geelen, Marc G. Besselink, Vincent E. de Meijer, Ignace H. J. T. de Hingh, Bert A. Bonsing, Philip R. de Reuver, François E.J.A. Willemssen, Pauline A. J. Vissers, Otto Visser, (unknown)	0
2	Feasibility, safety and preliminary efficacy of preoperative stereotactic radiotherapy on the future pancreatic neck transection margin to reduce the risk of pancreatic fistula after high-risk pancreatoduodenectomy (FIBROPANC): protocol for a multicentre, single-arm trial 2024 ·BMJ Open ·(unknown), (unknown), T. Hendriks, A. Bruynzeel, Joost J. Nuyttens, Martijn Intven, Lydi M.J.W. van Driel, Bas Groot Koerkamp, Olivier R. Busch, Jaap Stoker, Joanne Verheij, Arantza Fariña Sarasqueta, Michail Doukas, (unknown), Daan J. Lips, Erwin van der Harst, Geertjan van Tienhoven, Marc G. Besselink, Casper H.J. van Eijck	0
3	Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort 2024 ·Translational research ·(unknown), Mark P.G. Dings, (unknown), Arantza Fariña Sarasqueta, Cynthia Waasdorp, Gerrit K. Hooijer, Joanne Verheij, Jan Köster, Danny A. Zwijnenburg, Johanna W. Wilmink, Jan Paul Medema, Frederike Dijk, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma	2
4	Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease 2024 ·JHEP Reports ·Anne Linde Mak, (unknown), Anne‐Marieke van Dijk, Marian Troelstra, (unknown), (unknown), (unknown), (unknown), (unknown), Elizabeth Shumbayawonda, Jurgen H. Runge, Michail Doukas, Joanne Verheij, Ulrich Beuers, Max Nieuwdorp, Djuna L. Cahen, Aart J. Nederveen, Oliver J. Gurney‐Champion, Adriaan G. Holleboom	9
5	Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease: Liver DNA Methylation Analysis—A Systematic Review 2024 ·Cells ·(unknown), Abraham S. Meijnikman, (unknown), (unknown), Nerissa P. Denswil, Joanne Verheij, Wanderley Marques Bernardo, (unknown)	2
6	Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma 2024 ·Nature Communications ·Christel Ramirez, (unknown), Masami Ando‐Kuri, Marnix H. P. de Groot, (unknown), Zhijie Huang, (unknown), Roelof J.C. Kluin, Daan J. Kloosterman, Joanne Verheij, Jing Xu, Serena Vegna, Leila Akkari	15
7	Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia 2023 ·Pancreatology ·Nadine C.M. van Huijgevoort, (unknown), Selma J. Lekkerkerker, Olivier R. Busch, Marco Del Chiaro, Paul Fockens, (unknown), Joanne Verheij, Rogier P. Voermans, Marc G. Besselink, Jeanin E. van Hooft	10
8	Relief of symptoms and quality of life after conservative versus surgical treatment of benign liver tumors (CONSULT): a retrospective propensity score matched study 2023 ·HPB ·(unknown), (unknown), (unknown), Marcel J. van der Poel, Dewkoemar Ramsoekh, Geert Kazemier, Joanne Verheij, R. Bart Takkenberg, Marc G. Besselink, Joris I. Erdmann, Thomas M. van Gulik	1
9	Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients 2022 ·npj Precision Oncology ·Tessa J.J. de Bitter, Philip R. de Reuver, (unknown), Leonie I. Kroeze, M. Elisa Vink-Börger, Shannon van Vliet, Femke Simmer, Daniel von Rhein, Erik A. M. Jansen, Joanne Verheij, Carla M.L. van Herpen, Irıs D. Nagtegaal, Marjolijn J. L. Ligtenberg, Rachel S. van der Post	15
10	FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis 2021 ·Journal of Clinical Medicine ·Yasaman Vali, Jenny Lee, Jérôme Boursier, René Spijker, Joanne Verheij, M. Julia Brosnan, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad Hadi Zafarmand, (unknown)	42
11	Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis 2020 ·PLoS ONE ·Jenny Lee, Yasaman Vali, Jérôme Boursier, Kevin L. Duffin, Joanne Verheij, M. Julia Brosnan, Koos Zwinderman, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad Hadi Zafarmand	51
12	Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Manon E. Wildenberg, Gerrit K. Hooijer, Monique M.A. Verstegen, Luc J. W. van der Laan, Wouter J. de Jonge, Joanne Verheij, Cyriel Y. Ponsioen	12
13	Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients 2019 ·Scandinavian Journal of Gastroenterology ·Dirk P. van Asseldonk, Melek Simsek, Nanne K.H. de Boer, Bindia Jharap, Elisabeth Bloemena, G. den Hartog, (unknown), Marco C. Becx, Maurice G. Rüssel, Birgit I. Lissenberg‐Witte, (unknown), Chris J. Mulder, Joanne Verheij, Adriaan A. van Bodegraven	9
14	Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice 2018 ·Hepatology Communications ·Martine C. Morrison, Lars Verschuren, Kanita Salic, Joanne Verheij, Aswin Menke, Peter Y. Wielinga, Marta Iruarrizaga‐Lejarreta, Laurent Golé, Weimiao Yu, Scott Turner, Martien P. M. Caspers, Ibon Martínez‐Arranz, Elsbet Pieterman, Reinout Stoop, Arianne van Koppen, Anita M. van den Hoek, José M. Mato, Roeland Hanemaaijer, Cristina Alonso, Robert Kleemann	53
15	Tuberculosis presenting as a pancreatic cystic neoplasm 2018 ·BMJ Case Reports ·Niels van der Naald, Anton F. Engelsman, Marc Engelbrecht, Joanne Verheij, Marc G. Besselink, Olivier R. Busch, Thomas van Gulik	0
16	Disease activity in eosinophilic esophagitis is associated with impaired esophageal barrier integrity 2017 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Marijn J. Warners, Bram D. van Rhijn, Joanne Verheij, Andreas J. Smout, Albert J. Bredenoord	34
17	Incidence of eosinophilic esophagitis in the Netherlands continues to rise: 20‐year results from a nationwide pathology database 2017 ·Neurogastroenterology & Motility ·Marijn J. Warners, (unknown), Bram D. van Rhijn, Joanne Verheij, Annette H. Bruggink, Andreas J. Smout, Albert J. Bredenoord	23
18	IL-23 and IL-17 are not involved in hepatic ischemia reperfusion injury in mouse and man 2015 ·Journal of Clinical and Translational Research ·Pim B. Olthof, (unknown), Megan J. Reiniers, Milan Kos, Lindy K. Alles, M.A.W. Maas, Joanne Verheij, Thomas van Gulik, Michal Heger	4
19	Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy. 2014 ·PubMed ·Ferry A.L.M. Eskens, Karel J. van Erpecum, Koert P. de Jong, Otto M. van Delden, Heinz‐Josef Klümpen, Cornelis Verhoef, P. L. M. Jansen, Maurice A. A. J. van den Bosch, Alejandra Méndèz Romero, Joanne Verheij, Elisabeth Bloemena, Robert A. de Man	11
20	[Diagnostics and treatment of hepatocellular carcinoma: trends in the Netherlands in the period 2003-2011]. 2014 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Joanne Verheij, de Man, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact